moxisylyte has been researched along with Aging in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
"In aging eyes phenylephrine drops have no significant effect on the depth of the anterior chamber, whereas pilocarpine drops produce a significant shallowing." | 3.66 | Acute shallowing of the anterior chamber. ( Mapstone, R, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mapstone, R | 1 |
Buckley, C | 1 |
Curtin, DM | 1 |
Docherty, J | 1 |
Eustace, P | 1 |
2 other studies available for moxisylyte and Aging
Article | Year |
---|---|
Acute shallowing of the anterior chamber.
Topics: Acetazolamide; Aged; Aging; Anterior Chamber; Glaucoma; Humans; Intraocular Pressure; Iris; Middle A | 1981 |
Ageing and alpha 1 adrenoceptors in the iris.
Topics: Adult; Aged; Aged, 80 and over; Aging; Dose-Response Relationship, Drug; Humans; Iris; Moxisylyte; P | 1987 |